tiprankstipranks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Technical Analysis

Compare
563 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 4.92, suggesting Ascendis Pharma is a Sell.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 136.26, while Ascendis Pharma’s (ASND) share price is $154.58, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 133.44, while Ascendis Pharma’s (ASND) share price is $154.58, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Feb 22, 2025, 12:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
144.64
147.36
151.24
153.96
157.84
160.56
164.44
Fibonacci
147.36
149.88
151.44
153.96
156.48
158.04
160.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Feb 22, 2025, 12:54 PM
Period
Simple
Exponential
MA5
150.49Buy
148.97Buy
MA10
136.35Buy
141.72Buy
MA20
131.84Buy
136.26Buy
MA50
133.61Buy
133.44Buy
MA100
132.29Buy
133.16Buy
MA200
132.66Buy
134.97Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 141.72, while Ascendis Pharma’s (ASND) share price is $154.58, making it a Buy.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 133.16, while Ascendis Pharma’s (ASND) share price is $154.58, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $154.58 and Ascendis Pharma’s (ASND) 50-day simple moving average is 133.61, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $154.58 and Ascendis Pharma’s (ASND) 100-day simple moving average is 132.29, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $154.58 and Ascendis Pharma’s (ASND) 200-day simple moving average is 132.66, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Feb 22, 2025, 12:54 PM
Name
Value
Implied Action
RSI (14)
69.01
Neutral
STOCH (9,6)
94.72
Sell
STOCHRSI (14)
94.72
Sell
MACD (12,26)
4.92
Sell
ADX (14)
30.86
Neutral
Williams %R
-7.09
Sell
CCI (14)
167.05
Sell
ATR (14)
7.04
-
Ultimate Oscillator
68.17
Neutral
ROC
21.43
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 69.01, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 30.86, creating a Neutral signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is 167.05, creating a Sell signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 21.43, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 69.01, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 4.92, which suggests ASND is a Sell.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 150.49, which suggests ASND is a Buy.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 131.84, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 133.61, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 132.66, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -7.09, which suggests ASND is a Sell.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is 167.05, which suggests ASND is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis